相关实验视频

Updated: Jan 6, 2026

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

灵感来自于混合体的策略,为精密疗法量身定制多功能外体

Zhufeng Dong^1,2, Tieying Yin², Zhiqin Deng¹

¹School of Medicine, Chongqing University, Chongqing 400044, China.

Proceedings of the National Academy of Sciences of the United States of America

|September 9, 2025

概括

来自融合细胞的工程外体提供了针对性治疗的可扩展方法. 在阿尔茨海默氏症模型中,这些混合外体增强了微质功能,并清除了粉样β斑块,改善了认知能力.

科学领域:

生物医学是生物医学.
细胞生物学细胞生物学
纳米技术纳米技术

背景情况:

外体对向治疗有希望,但在修改和可扩展性方面面临挑战.
当前的工程方法往往缺乏一致性和大规模生产能力.

研究的目的:

开发一种通用和有效的策略,利用细胞融合设计多功能外体.
在阿尔茨海默氏病 (AD) 模型中证明混合细胞衍生的外体细胞 (H/Exos) 的治疗潜力.

主要方法:

通过介质干细胞 (MSC) 和中性粒细胞的细胞融合来设计多功能外体.
在AD小鼠模型中利用混合细胞衍生外体 (H/Exos) 进行向的输送和治疗干预.
评估了H/Exos对微质丰富度,基因表达,细胞功能和粉样β (Aβ) 清除的影响.

主要成果:

通过LFA-1/ICAM-1相互作用,H/Exos有效地准了AD受影响的大脑区域.
在接受H/Exos.治疗的AD小鼠中改善了认知功能.
H/Exos显著增加了微质丰富度,调节了它们的基因表达,增强了细胞活性,并促进了Aβ清除.

结论:

细胞融合为工程治疗外生体提供了一个多功能和可扩展的平台.
混合外体体通过调节微质细胞和清除Aβ细胞,对阿尔茨海默病具有显著的治疗潜力.
这种灵感来自混合体的策略推进了针对各种疾病的基于外体的个性化疗法.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.混合细胞混合细胞混合细胞介质细胞干细胞介质细胞干细胞微质分化的微质分化准治疗性的外体细胞.

更多相关视频

Isolation and Characterization of Exosomes from Skeletal Muscle Fibroblasts

Isolation and Characterization of Exosomes from Skeletal Muscle Fibroblasts

Published on: May 16, 2020

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

相关概念视频

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...